Pharmacological Topics of Bone Metabolism : A Novel Bisphosphonate for the Treatment of Periodontitis
スポンサーリンク
概要
- 論文の詳細を見る
It has been reported that the pharmacological characteristics of bisphosphonates vary depending on the side chain attached to the carbon atom of the P-C-P bond. TRK-530 is a novel synthetic bisphosphonate with an anti-oxidant methylthio-phenylthio side chain. This compound has been suggested to have both anti-inflammatory and anti–bone-resorbing effects. Such a compound could be effective for the treatment of diseases with excessive bone resorption accompanied by inflammation. We have been studying this compound as a potential therapeutic agent for periodontitis. To date, we have found that 1) TRK-530 inhibited osteoclastic bone resorption in animals and in bone organ culture, 2) both systemic and topical administration of TRK-530 prevented alveolar bone loss in animals with experimental periodontitis, 3) TRK-530 prevented prostaglandin E2 synthesis by inhibiting the expression of cyclooxygenase (COX)-2 mRNA, and 4) TRK-530 inhibited the formation of dental calculus. The above results suggest that TRK-530 might be useful for the treatment of alveolar bone loss in periodontitis.
- 社団法人 日本薬理学会の論文
- 2008-04-20
著者
-
SUZUKI Keiko
Department of Internal Medicine, Koga General Hospital
-
Yamada Shoji
Showa Univ.
-
SHINODA Hisashi
Department of Pharmacology, Tohoku University School of Dentistry
-
TAKEYAMA Sadaaki
Division of Dental Pharmacology, Department of Oral Biology ; Tohoku University Graduate School of D
-
MURAKAMI Shinobu
Department of Applied Pharmacology, Department of Oral Biology ; Tohoku University Graduate School o
-
YAMADA Shoji
Department of Dental Pharmacology, School of Dentistry, Showa University
-
Suzuki Keiko
Showa Univ.
-
Shinoda Hisashi
Department Of Applied Pharmacology Department Of Oral Biology ; Tohoku University Graduate School Of
-
Shinoda Hisashi
Department Of Applied Dental Pharmacology Tohoku University Graduate School Of Dentistry
-
Takeyama Sadaaki
Division Of Dental Pharmacology Department Of Oral Biology ; Tohoku University Graduate School Of De
-
Murakami Shinobu
Department Of Applied Pharmacology Department Of Oral Biology ; Tohoku University Graduate School Of
-
Suzuki Keiko
Department Of Internal Medicine Koga General Hospital
-
Yamada Shoji
Department Of Dental Pharmacology School Of Dentistry Showa University
-
Suzuki Keiko
Deparment Of Cardiology Cenler For Adut Diseases Osaka
-
Yamada Shoji
Department of Cellular Neurobiology, Brain Research Institute, Niigata University
関連論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- The characteristics of relapse in adult-onset minimal-change nephrotic syndrome
- Wegeners Granulomatosis Complicated by Intestinal Ulcer due to Cytomegalovirus Infection and by Thrombotic Thrombocytopenic Purpura
- Effects of Chronic Administration of Zonisamide, an Antiepileptic Drug, on Bone Mineral Density and Their Prevention With Alfacalcidol in Growing Rats
- Pharmacological Topics of Bone Metabolism : A Novel Bisphosphonate for the Treatment of Periodontitis
- Current Topics in Pharmacological Research on Bone Metabolism : Inhibitory Effects of Bisphosphonates on the Differentiation and Activity of Osteoclasts
- Risedronate Does Not Interfere with Bone Formation Coupled with Lipopolysaccharide-Stimulated Bone Resorption
- Characterization of a Novel Triphosphonooctaosylceramide from the Eggs of the Sea Hare, Aplysia kurodai^1
- Structural Analysis of a Novel Triphosphonoglycosphingolipid from the Egg of the Sea Hare, Aplysia kurodai
- The Study of Osteoporosis in Dentistry